Building a scale to measure the positives and negatives of new drugs

This survey seeks to support the development of a measurement scale for assessing both positive and negative effects of new drugs. The supplied content provides only the survey title and an access screen requiring human verification, so it does not explain which drugs are being studied, how benefits and harms are defined, how the scale will be constructed, or who is conducting the research. No conclusions, participant criteria, procedures, or findings are available from the supplied material. The central implication is that the project concerns systematic evaluation of drug-related outcomes, but its scientific scope and relevance to particular substances cannot be determined without additional survey information or study documentation.